97 Recruiting Metastatic Malignant Solid Neoplasm Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Interventions for Metastatic Malignant Solid Neoplasm
Related Conditions
Top Recruiting Metastatic Malignant Solid Neoplasm Studies
Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid Tumors
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 Expression
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
View Study & Checklist ➔Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔Improving Processes of Cancer Care Delivery at a Comprehensive Cancer Center
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Tumors, ONE SHOT Trial
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
View Study & Checklist ➔Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid Tumors
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers
📍 National Cancer Institute Developmental Therapeutics Clinic — Bethesda, Maryland
View Study & Checklist ➔Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
📍 City of Hope — Duarte, California
View Study & Checklist ➔Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
View Study & Checklist ➔MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers
📍 Mayo Clinic in Florida — Jacksonville, Florida
View Study & Checklist ➔